Financhill
Back

Cyclo Therapeutics Stock Predictions

Sell
37

CYTH
Cyclo Therapeutics

Last Price:
2.19
Seasonality Move:
44.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Cyclo Therapeutics Stock Forecast

  • Is Cyclo Therapeutics Stock Undervalued?
    The current Cyclo Therapeutics [CYTH] share price is $2.17. The Score for CYTH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CYTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Cyclo Therapeutics Stock Go Up Next Year?

Data Unavailable

Cyclo Therapeutics Stock Rating

Data Unavailable

Cyclo Therapeutics Stock Price History

Is CYTH stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTH is experiencing slight selling pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Type:
stock
Website:
cyclodex.com

52-Week Data

52-Week High:
8.39
52-Week Low:
1.82

Prediction Charts

Market Cap:
18.26M
Price in USD:
2.17
Volume:
8.71K
Beta:
-0.23

Technical Analysis

SMA50:
2.13
SMA100:
2.39
SMA200:
3.48
52-Wk Change:
-73.24%

Stock Predictions

  • Is Cyclo Therapeutics stock public?
    Yes, Cyclo Therapeutics is a publicly traded company.
  • What is the Cyclo Therapeutics stock quote today?
    The Cyclo Therapeutics stock price isĀ 2.17 USD today.
  • How to buy Cyclo Therapeutics stock online?
    You can buy Cyclo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-20 2.05 2.07 2.20 2.04
Jul-21 2.20 1.99 2.22 1.90
Jul-22 2.05 1.98 2.14 1.91
Jul-25 1.93 1.94 1.96 1.90
Jul-26 2.00 1.86 2.01 1.82
Jul-27 1.98 1.90 1.99 1.90
Jul-29 2.00 1.97 2.00 1.94
Aug-1 1.97 1.90 2.00 1.90
Aug-2 1.92 1.85 1.93 1.84
Aug-3 1.93 1.97 2.05 1.86
Aug-4 2.02 2.25 2.31 2.02
Aug-5 2.30 2.27 2.31 2.15
Aug-8 2.46 2.23 2.46 2.16
Aug-9 2.16 2.17 2.21 2.15

Cyclo Therapeutics Earnings

Data Unavailable

Cyclo Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.00 per share.

* Cyclo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.